ADMA Biologics - ADMA Market Value
ADMA Biologics (ADMA) relies on a closed-loop immunoglobulin production cycle, where the BIVIGAM drug ensures exclusive customer loyalty. High barriers to entry are established through unique blood purification processes and stringent FDA oversight. The environmental strategy is based on bio-waste recycling and energy efficiency, while the market capitalization stands at 2.82. The historical price action shown below clearly demonstrates the market position of this specialized medication manufacturer.
Comprehensive metric breakdowns and analytics for ADMA Corp (ADMA)
- current price and projected stock value:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital ADMA Biologics|ADMA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital ADMA Biologics|ADMA - Company Aggregate Debts|Debt to Book Capitalization Ratio ADMA Corp|ADMA - Company Long-Term Loans and Borrowings|Company Short-Term Debt ADMA Biologics|Quick Ratio admabiologics.com
- financial results and valuation multiples details:
ADMA - Net Profit|Future Profit ADMA Biologics|ADMA - Company Value to Net Income|Forward P/E Multiple ADMA Bio|ADMA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ADMA Corp|ADMA - Operating profit before deduction of amortization|Earnings per share for the last twelve months ADMA Biologics|ADMA - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months admabiologics.com|ADMA - Earnings growth in current year|Net earnings per share growth forecast for next year ADMA Biologics
Fundamental company analysis:ADMA (ADMA Biologics, Inc.)
The specifics of plasma-derived drug production and the implementation of energy-saving ESG technologies in ADMA Biologics (ADMA) laboratories directly impact the business's investment attractiveness. The company's total market capitalization consolidates the market value of all shares, transforming subjective investor expectations into objective multiple compression trends, which allows for an assessment of real capital resilience under tight monetary policy through the analysis of this curve.
Key competitors
Market Capitalization ARGX (argenx)|BNTX: Market Capitalization|ABVX - Market Value|Protagonist Corp (PTGX) - Market Valuation|IMVT: Market Capitalization|kiniksa.com (KNSA) - Market Capitalization|Market Value Grifols|Adaptive Biotech - Market Valuation|Market Capitalization CLDX|AUPH (Aurinia Corp) - Market Value|Market Capitalization BCRX (BioCryst)|Market Capitalization veratx.com VERA|DNTH - Market Value|Market Value PHVS (Pharvaris NV)|AbCellera (ABCL) - Market Value|Market Valuation Tourmaline|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|ACRS - Market Capitalization|KYTX: Market Capitalization|Market Capitalization TLSA|Market Value Cabaletta Bio|Market Valuation Ventyx Biosciences Inc. (VTYX)|Market Capitalization THTX|Market Capitalization Avalo Therapeutics Inc (AVTX)|Eledon Pharmaceuticals - Market Valuation|Market Value AGEN|Climb Bio - Market Capitalization|ZURA: Market Value|ATYR: Market Capitalization|ADAG - Market Capitalization|Market Value ImageneBio|Market Value Shattuck Therapeutics STTK|Market Value Equillium, Inc. (EQ)|Market Value CNTB (connectbiopharm.com)|Market Value Immunic IMUX|Atara Biotherapeutics, Inc. (ATRA) - Market Value|InflaRx GmbH - Market Capitalization|Market Capitalization x4pharma.com (XFOR)|ACET: Market Capitalization|CELU - Market Capitalization|INMB (INmune Bio Corp) - Market Capitalization|Market Valuation Barinthus Biotherapeutics Corp (BRNS)|Market Value Kezar Life Sciences (KZR)|Market Capitalization sabbiotherapeutics.com|Market Capitalization AKTX (Akari Therapeutics Plc)|Market Capitalization Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - Market Capitalization|GOVX (GeoVax Corp) - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Valuation ibioinc.com|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Capitalization XTL Biopharmaceuticals Ltd|Market Value Bolt Biotherapeutics (BOLT)|HCWB: Market Valuation|Market Capitalization APVO (Aptevo Therapeutics Inc.)|Market Value AIM|Aditxt Corp - Market Capitalization|GRI - Market Capitalization|XORTX (XRTX) - Market Value|Vyome Therapeutics - Market Value|Market Value Revelation Biosciences|Market Valuation indaptusrx.com (INDP)|Market Capitalization SCNI|Market Capitalization calcimedica.com (CALI)|Affimed N.V. - Market Valuation|Market Value ALLK|HOOKIPA - Market Capitalization|Market Capitalization IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation Ocean Biomedical Inc|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
